Selectivity in reductive elimination and organohalide transfer from methyl(aryl) benzylpalladium(IV) complexes of bidentate nitrogen donor ligands, PdBrMe(Ar)(CH2Ph)(L2)

The binding assessment with human serum albumin of novel six-coordinate Pt(IV) complexes, containing bidentate nitrogen donor/methyl ligands

The interactions between platinum complexes and human serum albumin (HSA) play crucial roles in the distribution, metabolism, and activity of platinum-based anticancer drugs. Octahedral platinum (IV) complexes represent a significant class of anticancer agents that display molecular pharmacological properties different from cisplatin. In this study, the interaction between two Pt(IV) complexes ...

Bidentate Schiff Base derived from quinolone Ligands Oxovanadium (IV) Complexes

Bidentate Isatin Schiff Base Ligands Oxovanadium (IV) Complexes

The aim of the present study is to synthesize the oxovanadium complex of the V3+ ion with isatin sciff bases. Spectroscopic methods have been used to confirm these models of complexation and to understand the structures of the species formed in methanolic solution. We also have isolated a complex of Vanadium (III) with isatin schiff bases in the solid phase.

Bidentate Isatin Schiff Base Ligands Oxovanadium (IV) Complexes

The aim of the present study is to synthesize the oxovanadium complex of the V3+ ion with isatin sciff bases. Spectroscopic methods have been used to confirm these models of complexation and to understand the structures of the species formed in methanolic solution. We also have isolated a complex of Vanadium (III) with isatin schiff bases in the solid phase.

the binding assessment with human serum albumin of novel six-coordinate pt(iv) complexes, containing bidentate nitrogen donor/methyl ligands

the interactions between platinum complexes and human serum albumin (hsa) play crucial roles in the distribution, metabolism, and activity of platinum-based anticancer drugs. octahedral platinum (iv) complexes represent a significant class of anticancer agents that display molecular pharmacological properties different from cisplatin. in this study, the interaction between two pt(iv) complexes ...